Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

The cellular composition of H3K27M gliomas Diffuse midline gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) are an aggressive type of childhood cancer with few options for treatment. Filbin et al. used a single-cell sequencing approach to study the oncogenic programs, genetics, and cellular hierarchies of H3K27M-glioma. Tumors were mainly composed of cells resembling oligodendrocyte precursor cells, whereas differentiated malignant cells were a smaller fraction. In comparison with other gliomas, these cancers had distinct oncogenic programs and stem cell–like profiles that contributed to their stable tumor-propagating potential. The analysis also identified a lineage-specific marker that may be useful in developing therapies. Science, this issue p. 331 Single-cell analyses of H3K27M glioma defines a putative developmental hierarchy that differs from other gliomas. Gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) arise primarily in the midline of the central nervous system of young children, suggesting a cooperation between genetics and cellular context in tumorigenesis. Although the genetics of H3K27M-glioma are well characterized, their cellular architecture remains uncharted. We performed single-cell RNA sequencing in 3321 cells from six primary H3K27M-glioma and matched models. We found that H3K27M-glioma primarily contain cells that resemble oligodendrocyte precursor cells (OPC-like), whereas more differentiated malignant cells are a minority. OPC-like cells exhibit greater proliferation and tumor-propagating potential than their more differentiated counterparts and are at least in part sustained by PDGFRA signaling. Our study characterizes oncogenic and developmental programs in H3K27M-glioma at single-cell resolution and across genetic subclones, suggesting potential therapeutic targets in this disease.

Tracy T Batchelor | Volker Hovestadt | Mariella G. Filbin | McKenzie L. Shaw | Liliana Goumnerova | Andreas Peyrl | Johannes Gojo | Thomas Czech | Christine Haberler | Aviv Regev | Keren Yizhak | Gad Getz | Christian Dorfer | Rameen Beroukhim | Maria Martinez-Lage | Keith L Ligon | David N Louis | Michelle Monje | Todd R Golub | Matthew P Frosch | Pratiti Bandopadhayay | Orit Rozenblatt-Rosen | Itay Tirosh | Dennis M Bonal | A. Regev | T. Golub | G. Getz | R. Beroukhim | K. Ligon | D. Louis | B. Bernstein | I. Tirosh | O. Rozenblatt-Rosen | Leah E. Escalante | Keren Yizhak | Christina C Luo | R. Mylvaganam | M. Frosch | M. Monje | V. Hovestadt | J. Mora | Peter van Galen | T. Batchelor | K. Wucherpfennig | C. Lavarino | L. Goumnerova | M. Martinez-Lage | M. Kieran | I. Slavc | C. Dorfer | T. Czech | K. Egervari | P. Bandopadhayay | G. Fritsch | K. Pelton | C. Haberler | N. Mathewson | J. Gojo | A. Carcaboso | Jaume Mora | Mario L Suvà | Angel M Carcaboso | M. Popović | N. Frank | Cyril Neftel | Kristine Pelton | Quang-De Nguyen | Ravindra Mylvaganam | Irene Slavc | Christopher W. Mount | Bradley E Bernstein | Gerhard Fritsch | Mark W Kieran | Peter van Galen | Kai W Wucherpfennig | Cinzia Lavarino | Nelli Frank | Mariella G Filbin | McKenzie L Shaw | Leah E Escalante | Nathan D Mathewson | Christine M Hebert | Kristof Egervari | Christopher Mount | Alexander Beck | Claire Sinai | Mara Popović | Amedeo Azizi | Claire Sinai | D. Bonal | A. Azizi | A. Peyrl | P. van Galen | Christine Hebert | Q. Nguyen | A. Beck | M. Suvà | Christina C. Luo | Cyril Neftel | C. Dorfer | Michelle Monje

[1]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[2]  Lars E. Borm,et al.  Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells , 2016, Cell.

[3]  Steven D Chang,et al.  Single-Cell RNAseq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma , 2017, bioRxiv.

[4]  I. Weissman,et al.  Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma , 2011, Proceedings of the National Academy of Sciences.

[5]  Shawn M. Gillespie,et al.  Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.

[6]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[7]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[8]  Jens Hjerling-Leffler,et al.  Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system , 2016, Science.

[9]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[10]  Kristian Cibulskis,et al.  ContEst: estimating cross-contamination of human samples in next-generation sequencing data , 2011, Bioinform..

[11]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[12]  Mariella G. Filbin,et al.  Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq , 2017, Science.

[13]  A. Krešo,et al.  Self-renewal as a therapeutic target in human colorectal cancer , 2013, Nature Medicine.

[14]  Dennis C. Friedrich,et al.  A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries , 2011, Genome Biology.

[15]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[16]  Mariella G. Filbin,et al.  Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma , 2016, Nature.

[17]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[18]  C. Allis,et al.  Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation , 2014, Science.

[19]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[20]  Trevor J Pugh,et al.  Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation , 2013, Nucleic acids research.

[21]  Trevor J Pugh,et al.  Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.

[22]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[23]  J. Maguire,et al.  Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.

[24]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[25]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[26]  David T. W. Jones,et al.  Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge , 2014, Nature Reviews Cancer.